Clinical review: Use of renal replacement therapies in special groups of ICU patients

Critical Care

Volumn 16, Issue 1, 2011, Pages

  Hoste, Eric A J ^a   Dhondt, Annemieke ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; CITRIC ACID; FONDAPARINUX; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; MANNITOL; NAFAMSTAT MESILATE; POLYMYXIN B; PROSTACYCLIN; PROSTAGLANDIN E1; PROTAMINE; UREA;

ABDOMINAL PRESSURE; ACCIDENTAL HYPOTHERMIA; ACIDOSIS; ACUTE KIDNEY FAILURE; ACUTE ON CHRONIC LIVER FAILURE; ANAPHYLAXIS; ANTICOAGULATION; BLOOD BRAIN BARRIER; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; BLOOD FILTRATION; BRAIN BLOOD FLOW; BRAIN DISEASE; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN PERFUSION; BURN; CONGESTIVE HEART FAILURE; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS HEMODIALYSIS; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; DEMYELINATION; DIALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG HALF LIFE; EXTRACORPOREAL CIRCULATION; GENOMIC INSTABILITY; HEART DISEASE; HEMODIALYSIS; HEMOFILTRATION; HEMOPERFUSION; HEPARIN INDUCED THROMBOCYTOPENIA; HEPATORENAL SYNDROME; HUMAN; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; INTENSIVE CARE UNIT; INTOXICATION; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; LACTIC ACIDOSIS; LEUKOPENIA; LIVER FUNCTION; LOADING DRUG DOSE; PERFUSION PRESSURE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; SEPSIS; SIDE EFFECT; SINGLE DRUG DOSE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOPLASTIN TIME; TREATMENT INDICATION; ULTRAFILTRATION; UREA BLOOD LEVEL;

EID: 84856006672     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10499     Document Type: Review

References (81)

1. Hoste EAJ, Schurgers M. Epidemiology of AKI: how big is the problem?. Crit Care Med 2008, 36:S1-S4. 10.1097/01.CCM.0000296275.47600.B3, 18158468.
2. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 2006, 17:1135-1142. 10.1681/ASN.2005060668, 16495381.
3. Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 2006, 17:1143-1150. 10.1681/ASN.2005091017, 16495376.
4. Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, Fliser D. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 2004, 43:342-349. 10.1053/j.ajkd.2003.10.021, 14750100.
5. Phu NH, Hien TT, Mai NT, Chau TT, Chuong LV, Loc PP, Winearls C, Farrar J, White N, Day N. Hemofiltration and peritoneal dialysis in infectionassociated acute renal failure in Vietnam. N Engl J Med 2002, 347:895-902. 10.1056/NEJMoa020074, 12239258.
6. Gabriel DP, Caramori JT, Martim LC, Barretti P, Balbi AL. High volume peritoneal dialysis vs daily hemodialysis: a randomized, controlled trial in patients with acute kidney injury. Kidney Int Suppl 2008, 108:S87-S93.
7. Gabriel DP, Caramori JT, Martin LC, Barretti P, Balbi AL. Continuous peritoneal dialysis compared with daily hemodialysis in patients with acute kidney injury. Perit Dial Int 2009, 29(Suppl 2):S62-S71.
8. George J, Varma S, Kumar S, Thomas J, Gopi S, Pisharody R. Comparative study of continuous venovenous hemodiafiltration and peritoneal dialysis in critically ill patients with acute kidney injury: a pilot study. Perit Dial Int 2011, 31:422-429. 10.3747/pdi.2009.00231, 21357934.
9. Ricci Z, Ronco C, D'Amico G, De Felice R, Rossi S, Bolgan I, Bonello M, Zamperetti N, Petras D, Salvatori G, Dan M, Piccinni P. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant 2006, 21:690-696. 10.1093/ndt/gfi296, 16326743.
10. Pinnick RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 1983, 308:258-261. 10.1056/NEJM198302033080506, 6848936.
11. Davenport A, Tolwani A. Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. NDT Plus 2009, 2:439-447.
12. Oudemans-van Straaten HM. Citrate anticoagulation for continuous renal replacement therapy in the critically ill. Blood Purif 2010, 29:191-196. 10.1159/000245646, 20093826.
13. Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 2005, 20:155-161. 10.1016/j.jcrc.2005.01.001, 16139156.
14. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004, 30:260-265. 10.1007/s00134-003-2047-x, 14600809.
15. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005, 67:2361-2367. 10.1111/j.1523-1755.2005.00342.x, 15882280.
16. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009, 37:545-552. 10.1097/CCM.0b013e3181953c5e, 19114912.
17. Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011, 26:232-239. 10.1093/ndt/gfq575, 20876598.
18. Darby JPJ, Sorensen RJ, O'Brien TF, Teschan PE. Efficient heparin assay for monitoring regional heparinization and hemodialysis. N Engl J Med 1960, 262:654-657. 10.1056/NEJM196003312621304, 13814070.
19. Teschan P, Baxter C, O'Brian T, Freyhof J, Hall W. Prophylactic hemodialysis in the treatment of actue renal failure. Ann Intern Med 1960, 53:992-1016.
20. European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association European Best Practice Guidelines. Section V. Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system. Nephrol Dial Transplant 2002, 17(Suppl 7):63-71. European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association.
21. Kozek-Langenecker SA, Spiss CK, Gamsjager T, Domenig C, Zimpfer M. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial. Wien Klin Wochenschr 2002, 114:96-101.
22. Davenport A, Will EJ, Davison AM. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pumpdriven extracorporeal circuits in patients with combined acute renal and hepatic failure. Nephron 1994, 66:431-437. 10.1159/000187859, 8015647.
23. Davenport A, Will EJ, Davison AM. The effect of prostacyclin on intracranial pressure in patients with acute hepatic and renal failure. Clin Nephrol 1991, 35:151-157.
24. Beiderlinden M, Treschan TA, Gorlinger K, Peters J. Argatroban anticoagulation in critically ill patients. Ann Pharmacother 2007, 41:749-754. 10.1345/aph.1H569, 17440009.
25. Murray PT, Reddy BV, Grossman EJ, Hammes MS, Trevino S, Ferrell J, Tang I, Hursting MJ, Shamp TR, Swan SK. A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease. Kidney Int 2004, 66:2446-2453. 10.1111/j.1523-1755.2004.66022.x, 15569338.
26. Link A, Girndt M, Selejan S, Mathes A, Bohm M, Rensing H. Argatroban for anticoagulation in continuous renal replacement therapy. Crit Care Med 2009, 37:105-110. 10.1097/CCM.0b013e3181932394, 19050602.
27. Sun X, Chen Y, Xiao Q, Wang Y, Zhou J, Ma Z, Xiang J, Chen X. Effects of argatroban as an anticoagulant for intermittent veno-venous hemofiltration (IVVH) in patients at high risk of bleeding. Nephrol Dial Transplant 2011, 26:2954-2959. 10.1093/ndt/gfq805, 21303963.
28. Sombolos KI, Fragia TK, Gionanlis LC, Veneti PE, Bamichas GI, Fragidis SK, Georgoulis IE, Natse TA. Use of fondaparinux as an anticoagulant during hemodialysis: a preliminary study. Int J Clin Pharmacol Ther 2008, 46:198-203.
29. Vanholder R, Dhondt A. Recombinant hirudin: clinical pharmacology and potential applications in nephrology. BioDrugs 1999, 11:417-429. 10.2165/00063030-199911060-00006, 18031153.
30. Benz K, Nauck MA, Bohler J, Fischer KG. Hemofiltration of recombinant hirudin by different hemodialyzer membranes: implications for clinical use. Clin J Am Soc Nephrol 2007, 2:470-476. 10.2215/CJN.02550706, 17699453.
31. Schortgen F, Soubrier N, Delclaux C, Thuong M, Girou E, Brun-Buisson C, Lemaire F, Brochard L. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients. Usefulness of practice guidelines. Am J Respir Crit Care Med 2000, 162:197-202.
32. Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, Pallot J-L, Chiche J-D, Taupin P, Landais P, . Dhainaut JF; Hemodiafe Study Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006, 368:379-385. 10.1016/S0140-6736(06)69111-3, 16876666, Dhainaut JF; Hemodiafe Study.
33. Vanholder R, Van Biesen W, Hoste E, Lameire N. Pro/Con debate: Continuous versus intermittent dialysisfor acute kindey injury: a never-ending story yet approaching the finish?. Crit Care 2011, 15:204.
34. Davenport A, Will EJ, Losowsky MS. Rebound surges of intracranial pressure as a consequence of forced ultrafiltration used to control intracranial pressure in patients with severe hepatorenal failure. Am J Kidney Dis 1989, 14:516-519.
35. Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993, 21:328-338. 10.1097/00003246-199303000-00007, 8440100.
36. Davenport A, Will EJ, Losowsky MS, Swindells S. Continuous arteriovenous haemofiltration in patients with hepatic encephalopathy and renal failure. Br Med J (Clin Res Ed) 1987, 295:1028. 10.1136/bmj.295.6605.1028, 1248075, 3120861.
37. Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL, Blei AT, Fontana RJ, McGuire BM, Rossaro L, Smith AD, Lee WM. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007, 35:2498-2508. 10.1097/01.CCM.0000287592.94554.5F, 17901832.
38. Davenport A. Anticoagulation options for patients with heparin-induced thrombocytopenia requiring renal support in the intensive care unit. Contrib Nephrol 2007, 156:259-266.
39. Davenport A. Practical guidance for dialyzing a hemodialysis patient following acute brain injury. Hemodial Int 2008, 12:307-312. 10.1111/j.1542-4758.2008.00271.x, 18638083.
40. De laet I, Citerio G, Malbrain ML. The influence of intraabdominal hypertension on the central nervous system: current insights and clinical recommendations, is it all in the head?. Acta Clin Belg Suppl 2007, 1:89-97.
41. Hunter JD, Damani Z. Intra-abdominal hypertension and the abdominal compartment syndrome. Anaesthesia 2004, 59:899-907. 10.1111/j.1365-2044.2004.03712.x, 15310355.
42. Huang WY, Weng WC, Peng TI, Ro LS, Yang CW, Chen KH. Central pontine and extrapontine myelinolysis after rapid correction of hyponatremia by hemodialysis in a uremic patient. Ren Fail 2007, 29:635-638. 10.1080/08860220701392314, 17654329.
43. Tarhan NC, Agildere AM, Benli US, Ozdemir FN, Aytekin C, Can U. Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: MRI of the brain. AJR Am J Roentgenol 2004, 182:809-816.
44. Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 2007, 120:S1-S21.
45. Oo TN, Smith CL, Swan SK. Does uremia protect against the demyelination associated with correction of hyponatremia during hemodialysis? A case report and literature review. Semin Dial 2003, 16:68-71. 10.1046/j.1525-139X.2003.03015.x, 12535304.
46. Soupart A, Penninckx R, Stenuit A, Decaux G. Azotemia (48 h) decreases the risk of brain damage in rats after correction of chronic hyponatremia. Brain Res 2000, 852:167-172. 10.1016/S0006-8993(99)02259-3, 10661508.
47. Ostermann M, Dickie H, Tovey L, Treacher D. Management of sodium disorders during continuous haemofiltration. Crit Care 2010, 14:418. 10.1186/cc8650, 2911705, 20519032.
48. Arieff AI. Dialysis disequilibrium syndrome: current concepts on pathogenesis and prevention. Kidney Int 1994, 45:629-635. 10.1038/ki.1994.84, 8196263.
49. Patel N, Dalal P, Panesar M. Dialysis disequilibrium syndrome: a narrative review. Semin Dial 2008, 21:493-498. 10.1111/j.1525-139X.2008.00474.x, 18764799.
50. Rodrigo F, Shideman J, McHugh R, Buselmeier T, Kjellstrand C. Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. Ann Intern Med 1977, 86:554-561.
51. Trotter JF. Practical management of acute liver failure in the intensive care unit. Curr Opin Crit Care 2009, 15:163-167. 10.1097/MCC.0b013e3283293114, 19578326.
52. Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009, 361:1279-1290. 10.1056/NEJMra0809139, 19776409.
53. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000, 6:277-286. 10.1053/lv.2000.6355, 10827226.
54. Rifai K, Kribben A, Gerken G, Haag S, Herget-Rosenthal S, Treichel U, Betz C, Sarrazin C, Van Vlierberghe H, Hoste E, Escorsell A, Gines P, Hafer C, Schuchmann M, Galle PR, Bernardi M, Caraceni P, Àbeles R, Frieder-Berr Knotek M, Kozik-Jaromin J. A prospective randomized controlled multicenter study of extracorporeal liver support by fractionated plasma separation and absorption (Prometheus (R)) in patients with acute-onchronic liver failure (HELIOS study) [abstract]. Hepatology 2010, 52:333A.
55. Trotter JF. Coagulation abnormalities in patients who have liver disease. Clin Liver Dis 2006, 10:665-678. x-xi, 10.1016/j.cld.2006.08.006, 17162234.
56. Wada H, Usui M, Sakuragawa N. Hemostatic abnormalities and liver diseases. Semin Thromb Hemost 2008, 34:772-778. 10.1055/s-0029-1145259, 19214915.
57. Peters N, Jay N, Barraud D, Cravoisy A, Nace L, Bollaert PE, Gibot S. Metforminassociated lactic acidosis in an intensive care unit. Crit Care 2008, 12:R149. 10.1186/cc7137, 2646313, 19036140.
58. Levraut J, Ciebiera JP, Jambou P, Ichai C, Labib Y, Grimaud D. Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med 1997, 25:58-62. 10.1097/00003246-199701000-00013, 8989177.
59. Vuylsteke S, Dhondt A, Danneels C, De Waele J, Blot S, Hoste E. Initiation of renal replacement therapy in patients with acute kidney injury and severe lactic acidosis [abstract]. Critical Care 2008, 12(Suppl 2):P479..
60. Costanzo MR, Saltzberg M, O''Sullivan J, Sobotka P. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 2005, 46:2047-2051. 10.1016/j.jacc.2005.05.099, 16325040.
61. Costanzo MR, Ronco C. Extracorporeal fluid removal in heart failure patients. Contrib Nephrol 2010, 165:236-243.
62. Sanchez JE, Ortega T, Rodriguez C, Diaz-Molina B, Martin M, Garcia-Cueto C, Vidau P, Gago E, Ortega F. Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant 2010, 25:605-610. 10.1093/ndt/gfp484, 19783594.
63. Cnossen N, Kooman JP, Konings CJ, van Dantzig JM, van der Sande FM, Leunissen K. Peritoneal dialysis in patients with congestive heart failure. Nephrol Dial Transplant 2006, 21(Suppl 2):ii63-ii66.
64. Brusselaers N, Monstrey S, Colpaert K, Decruyenaere J, Blot SI, Hoste EA. Outcome of acute kidney injury in severe burns: a systematic review and meta-analysis. Intensive Care Med 2010, 36:915-925. 10.1007/s00134-010-1861-1, 20333353.
65. Eloot S, Dhondt A, Hoste E, Verstraete A, De Waele J, Colpaert K, Hoeksema H, Tromp F, Vanholder R. How to remove accumulated iodine in burn-injured patients. Nephrol Dial Transplant 2010, 25:1614-1620. 10.1093/ndt/gfp647, 19965987.
66. Caluwe R, Vanholder R, Dhondt A. Hemodialysis as a treatment of severe accidental hypothermia. Artif Organs 2010, 34:237-239. 10.1111/j.1525-1594.2009.00837.x, 20665964.
67. Temmerman W, Dhondt A, Vandewoude K. Acute isoniazid intoxication: seizures, acidosis and coma. Acta Clin Belg 1999, 54:211-216.
68. Cohen DL, Post J, Ferroggiaro AA, Perrone J, Foster MH. Chronic salicylism resulting in noncardiogenic pulmonary edema requiring hemodialysis. Am J Kidney Dis 2000, 36:E20. 10.1053/ajkd.2000.16223, 10977813.
69. Glisson JK, Vesa TS, Bowling MR. Current management of salicylate-induced pulmonary edema. South Med J 2011, 104:225-232. 10.1097/SMJ.0b013e318205e548, 21297545.
70. Dhondt A, Verstraete A, Vandewoude K, Segers H, Eloot S, Decruyenaere J, Vanholder R. Efficiency of the Genius batch hemodialysis system with low serum solute concentrations: the case of lithium intoxication therapy. Am J Kidney Dis 2005, 46:e95-e99. 10.1053/j.ajkd.2005.08.001, 16253717.
71. Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 2002, 62:986-996. 10.1046/j.1523-1755.2002.00509.x, 12164882.
72. Uchino S, Morimatsu H, Bellomo R, Silvester W, Cole L. End-stage renal failure patients requiring renal replacement therapy in the intensive care unit: incidence, clinical features, and outcome. Blood Purif 2003, 21:170-175. 10.1159/000069156, 12601260.
73. Rocha E, Soares M, Valente C, Nogueira L, Bonomo HJ, Godinho M, Ismael M, Valenca RV, Machado JE, Maccariello E. Outcomes of critically ill patients with acute kidney injury and end-stage renal disease requiring renal replacement therapy: a case-control study. Nephrol Dial Transplant 2009, 24:1925-1930. 10.1093/ndt/gfn750, 19164319.
74. Lavaud S, Paris B, Maheut H, Randoux C, Renaux JL, Rieu P, Chanard J. Assessment of the heparin-binding AN69 ST hemodialysis membrane: II. Clinical studies without heparin administration. ASAIO J 2005, 51:348-351. 10.1097/01.mat.0000169121.09075.53, 16156297.
75. Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, Ronco C. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002, 30:100-106. 10.1097/00003246-200201000-00016, 11902250.
76. Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 2009, 37:803-810. 10.1097/CCM.0b013e3181962316, 19237881.
77. Ratanarat R, Brendolan A, Ricci Z, Salvatori G, Nalesso F, Cal M, Cazzavillan S, Petras D, Bonello M, Bordoni V, Cruz D, Techawathanawanna N, Ronco C. Pulse high-volume hemofiltration in critically ill patients: a new approach for patients with septic shock. Semin Dial 2006, 19:69-74. 10.1111/j.1525-139X.2006.00121, 16423184.
78. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR. Prospective evaluation of short-term, high volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000, 28:3581-3587. 10.1097/00003246-200011000-00001, 11098957.
79. Cruz D, Perazella M, Bellomo R, de Cal M, Polanco N, Corradi V, Lentini P, Nalesso F, Ueno T, Ranieri VM, Ronco C. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007, 11:R47. 10.1186/cc5780, 2206475, 17448226.
80. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009, 301:2445-2452. 10.1001/jama.2009.856, 19531784.
81. Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, Dan M, Irone M, La Greca G, Inguaggiato P, Maggiore U, De Nitti C, Wratten ML, Ricci Z, Tetta C. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002, 30:1250-1255. 10.1097/00003246-200206000-00015, 12072677.